Clinical Trial Update: Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating metabolomic and inflammatory effects of oral aspirin in individuals at risk for melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: University of Utah | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED